Latest News
BESS 2013 Meeting - [ 18.06.2013 ]
The BESS (British Elbow & Shoulder Society) meeting will take place from 19 - 21 June in Leicester. Come and visit us on stand 41.
[ read more + ]
New Product launch: REMOGEN OMEGA - [ 22.03.2013 ]
A new eye care product is now available from TRB Chemedica: REMOGEN OMEGA. They are preservative-free eye drops containing Omega-3 fatty acids and...
[ read more + ]
New Clinical Study on Ostenil Tendon - [ 15.03.2013 ]
A new clinical study on the efficacy and safety of OSTENIL Tendon is now available. It was conducted in 2012 by German doctor, N Lynen.
[ read more + ]
ISO Accreditation Retained - [ 04.02.2013 ]
TRB Chemedica are very pleased to announce that our ISO 9001 accreditation was renewed on Friday 1st February.
[ read more + ]
Ostenil at the Olympics - [ 06.11.2012 ]
Ostenil® participating at the London 2012 Olympic Games! Ostenil®, Ostenil® Plus and Ostenil® Mini were the only Hyaluronic Acid (or: Sodium...
[ read more + ]
VISMED GEL MULTI available on Prescription! - [ 29.10.2012 ]
We are pleased to announce that VISMED® GEL MULTI has been granted reimbursed status by NHS Prescription Services.
[ read more + ]
VISCOSEAL: New Syringe Presentation - [ 18.09.2012 ]
Coming to a theatre near you! Viscoseal Syringe has arrived! The successor to Viscoseal is now presented in a 10ml pre-fiilled syringe.
[ read more + ]
New Product Launch: OSTENIL TENDON - [ 30.04.2012 ]
TRB Chemedica launch new treatment for tendon disorders, Ostenil Tendon, for injection around the affected tendon or into the tendon sheath.
[ read more + ]
Aid for SunShine Foundation - [ 27.04.2012 ]
TRB Chemedica (UK) Ltd helps to make life better for some of the least fortunate children in one of the poorest parts of India.
[ read more + ]
Ostenil Plus Article: Efficacy & Safety - [ 30.03.2012 ]
Abstract:
Efficacy and safety of a single intraarticular injection of 2% sodium hyaluronate
+ mannitol in knee osteoarthritis over a 6 month...
[ read more + ]
Design Award for Vismed multi - [ 14.02.2012 ]
The new Vismed multi bottle wins a prize: the Paris Aerosol and Dispensing Award 2012!
[ read more + ]
Viscoseal Round Table Meeting - [ 26.01.2012 ]
A report on a roundtable meeting in January 2011 in Austria is now available. Dr S Egger (Austria), Dr Muthu Jeyam (UK), Prof C Erggelet...
[ read more + ]
Passed with Distinction! - [ 10.11.2011 ]
Two of our new colleagues at TRB Chemedica (UK) Ltd have passed their ABPI exam with distinction.
[ read more + ]
New VISMED MULTI bottle out now! - [ 11.10.2011 ]
Vismed multi is now available in a new bottle. Just squeeze! Still 0.18% Vismed, still preservative free, but much simpler to use than the old bottle.
[ read more + ]
TRB Chemedica (UK) Ltd achieves ISO 9001 Registration - [ 01.03.2011 ]
Keele based Bio-technology Company TRB Chemedica has achieved the internationally recognised ISO 9001 standard establishing it as one of the leaders...
[ read more + ]
Announcement: VISMED Gel available on prescription - [ 25.02.2011 ]
Vismed gel has been added to the drug tariff, joining Vismed and Vismed multi.
[ read more + ]
New Product Launch: Vismed wash - [ 27.08.2010 ]
The first eye rinsing solution containing sodium hyaluronate (hyaluronic acid), VISMED wash is helpful to flush away mucus, dust, pollen, and...
[ read more + ]
New Product launch: Ostenil Plus - [ 24.05.2010 ]
Ostenil Plus is now available from TRB Chemedica (UK) Ltd.
[ read more + ]
Announcement: Credit Card Payments Now Possible - [ 13.01.2010 ]
We can now accept payment by Credit Card over the telephone.
[ read more + ]
ASHES 2009: Flintoff still at the races thanks to an injection of horse bacteria - [ 22.07.2009 ]
ASHES 2009: Flintoff receives Ostenil injections to be able to continue to play in the Test.
[ read more + ]
New US Vismed Study Results - [ 11.06.2009 ]
This study demonstrates the efficacy of sodium hyaluronate solution 0.18% (Vismed) in the treatment of dry eye disease. Please read more in our...
[ read more + ]
Pharmaceutical Field Article - TRB Chemedica - [ 17.02.2007 ]
What do you do if you want to work in the UK Pharma industry but the prospect of
working for one of the global giants that dominate the market no...
[ read more + ]